All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AGRX / Agile Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
| OREX / Orexigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
| / Array BioPharma, Inc.
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| JUNO / Juno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| TTOO / T2 Biosystems, Inc.
|
|
|
|
|
|
|
|
| WGBS / WaferGen Bio-Systems, Inc.
|
|
|
|
|
|
|
|
| SCMP / Sucampo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OCRX / Ocera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| TROV / TrovaGene, Inc.
|
|
|
|
|
|
|
|
| ZSPH / ZS Pharma, Inc.
|
|
|
|
|
|
|
|
| TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
| REGN / Regeneron Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
| LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TXMD / TherapeuticsMD, Inc.
|
|
|
|
|
|
|
|
| DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
| RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
| BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CELG / Celgene Corp.
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RMTI / Rockwell Medical, Inc.
|
|
|
|
|
|
|
|
| OMER / Omeros Corporation
|
|
|
|
|
|
|
|
| AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| H03579101 / Auris Medical Holding Ltd
|
|
|
|
|
|
|
|
| MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BBI / Brickell Biotech Inc
|
|
|
|
|
|
|
|
| NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
| LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| VXRT / Vaxart, Inc.
|
|
|
|
|
|
|
|
